A. N. Rai, A. Basu / Tetrahedron Letters 44 (2003) 2267–2269
2269
References
J=9.7); 13C NMR (100 MHz) l 25.5, 32.5, 54.5, 55.3,
63.6, 74.7, 113.8, 128.8, 131.3, 158.9, 208.2; HRMS calcd
for [C14H20O3+Na]+ 259.1310, obsd. 259.1302.
1. Green, T. W.; Wuts, P. G. M. Protective Groups in
Organic Synthesis; John Wiley & Sons: New York, 1999.
2. Hinklin, R. J.; Kiessling, L. L. Org. Lett. 2002, 4, 1131–
1133.
3. (a) Takaku, H.; Ueda, S.; Ito, T. Tetrahedron Lett. 1983,
24, 5363–5366; (b) Nakajima, N.; Horita, K.; Abe, R.;
Yonemitsu, O. Tetrahedron Lett. 1988, 29, 4139–4142; (c)
Adams, E.; Hiegemann, M.; Duddeck, H.; Welzel, P.
Tetrahedron 1990, 46, 5975–5992.
4. (a) Audia, J. E.; Boisvert, L.; Patten, A. D.; Villalobos, A.;
Danishefsky, S. J. J. Org. Chem. 1989, 54, 3738–3740; (b)
Reddy, K. K.; Saady, M.; Falck, J. R.; Whited, G. J. Org.
Chem. 1995, 60, 3385–3390; (c) Fukase, Y.; Zhang, S.-Q.;
Iseki, K.; Oikawa, M.; Fukase, K.; Kusumoto, S. Synlett
2001, 1693–1698; (d) Karst, N.; Jacquinet, J.-C. Eur. J.
Org. Chem. 2002, 815–825.
5. (a) Kamaike, K.; Tsuchiya, H.; Imai, K.; Takaku, H.
Tetrahedron 1986, 42, 4701–4711; (b) Nakajima, N.; Saito,
M.; Ubukata, M. Tetrahedron Lett. 1998, 39, 5565–5568;
(c) Hannesian, S.; Huynh, H. K. Tetrahedron Lett. 1999,
40, 671–674; (d) Sharma, G. V. M.; Mahalingam, A. K. J.
Org. Chem. 1999, 64, 8943–8944; (e) Nakano, M.; Kikuchi,
W.; Matsuo, J.; Mukaiyama, T. Chem. Lett. 2001, 424–
425.
6. Kobayashi, S.; Sugiura, M.; Kitagawa, H.; Lam, W. W.-L.
Chem. Rev. 2002, 102, 2227–2302. Lanthanide triflates
have been used for the activation of glycosyl trichloroace-
timidates. See—Adinolfi, M.; Barone, G.; Iadonisi, A.;
Mangoni, L.; Schiattarella, M. Tetrahedron Lett. 2001, 42,
5967–5969.
7. When the reaction was carried out in wet toluene using
para-methoxybenzyl alcohol in place of the imidate 2, no
product was observed, indicating that etherification in
entry 11 proceeded via the imidate and hydrolysis of 2 was
not significant under the reaction conditions.
8. Representative procedure for PMB protection using
La(OTf)3: PMBTCA was prepared via the method of
Audia et al. (Ref. 4a). All PMB ethers with the exception
of that derived from 11 were prepared using the represen-
tative procedure described below. A solution of menthol
(20 mg, 0.128 mmol) and p-methoxybenzyl trichloroace-
timidate (54 mg, 0.192 mmol) in toluene (3 ml) was treated
with La(OTf)3 (4 mg, 0.006 mmol) at room temperature.
After completion of the reaction (<5 min), the reaction
mixture was concentrated and purified by column chro-
matography (1:9 ethyl acetate:hexane) to afford 30 mg
(85%) of 3.
Compound 6: Rf=0.6 (ethyl acetate/hexane, 1/4); 1H
NMR (300 MHz) l 3.40 (s, 3H), 3.53 (dd, 1H, J=9.2,
3.4), 3.57 (t, 1H, J=9.5), 3.69 (t, 1H, J=10), 3.78 (s, 3H),
3.82 (dt, 1H, J=8.1, 4.5), 4.02 (t, 1H, J=9.2), 4.26 (dd,
1H, J=9.8, 4.5), 4.58 (d, 1H, J=3.6), 4.67–4.87 (ab, 2H,
J=12.1), 4.74–4.85 (ab, 2H, J=10.8), 5.54 (s, 1H), 6.82 (d,
2H, J=8.5), 7.25–7.50 (m, 12 H); 13C NMR (100 MHz) l
55.1, 55.2, 62.2, 68.9, 73.6, 74.9, 78.2, 79.1, 82.0, 99.2,
101.1, 113.6, 125.9, 127.8, 128.0, 128.1, 128.4, 128.8, 129.6,
130.8, 137.4, 138.1, 159.1; HRMS calcd for [C29H32O7+H]+
493.2226, obsd. 493.2246.
Compound 7: Rf=0.7 (ethyl acetate/hexane, 1/1); 1H
NMR (300 MHz) l 2.02 (s, 3H), 2.07 (s, 6H), 3.37 (s, 3H),
3.60 (t, 1H, J=9.2), 3.80 (s, 3H), 3.88 (ddd, 1H, J=9.9,
4.1, 2.3), 4.23 (dd, 1H, J=12, 4.2), 4.31 (dd, 1H, J=12,
2.3), 4.44–4.56 (ab, 2H, J=10.8), 4.82–4.86 (m, 2H), 5.51–
5.58 (m, 1H), 6.85–6.88 (m, 2H), 7.17–7.19 (m, 2H); 13C
NMR (100 MHz) l 20.7, 20.8, 20.9, 55.2, 55.3, 62.6, 68.3,
71.2, 72.2, 74.1, 75.3, 96.8, 113.9, 129.3, 129.8, 159.5,
169.8, 170.4, 171.6; HRMS calcd for [C21H28O10+Na]+
463.1580, obsd. 463.1579.
Compound 8: Rf=0.5 (ethyl acetate/hexane, 9/1); 1H
NMR (300 MHz) l 1.21 (d, 3H, J=6.3), 3.76 (s, 3H), 4.12
(dq, 1H, J=6.3, 2.1), 4.17–4.41 (ab, 2H, J=11.5), 4.37–
4.41 (dd, 1H, J=9.5, 2.2), 5.06–5.17 (ab, 2H, J=13), 5.12
(s, 2H), 5.37 (d, 1H, J=9.6), 6.78–6.82 (m, 2H), 7.05–7.08
(m, 2H), 7.23–7.36 (m, 10H); 13C NMR (100 MHz) l 16.3,
55.2, 58.8, 67.0, 67.2, 70.4, 73.8, 113.7, 127.9, 128.1, 128.3,
128.4, 128.49, 128.54, 129.2, 129.8, 135.3, 136.3, 156.8,
159.2, 170.7; HRMS calcd for [C27H29NO6+Na]+ 486.1893,
obsd. 486.1893.
Compound 9: Rf=0.5 (ethyl acetate/hexane, 8/2); 1H
NMR (300 MHz) l 1.19 (d, 3H, J=6.3), 2.06 (s, 3H), 3.67
(s, 3H), 3.80 (s, 3H), 4.10 (dq, 1H, J=6.3, 2.2), 4.28–4.51
(ab, 2H, J=11.4), 4.66 (dd, 2H, J=9.3 2.2), 6.16 (d, 1H,
J=8.7), 6.85–6.89 (m, 2H), 7.16–7.19 (m, 2H); 13C NMR
(100 MHz) l 16.3, 23.2, 52.3, 55.3, 56.6, 70.5, 73.8, 113.8,
129.4, 129.8, 159.3, 170.5, 171.2; HRMS calcd for
[C15H21NO5+Na]+ 318.1317 obsd. 318.1312.
Compound 10: Rf=0.3 (ethyl acetate/hexane, 7/93); 1H
NMR (300 MHz) l 0.09 (s, 6H), 0.90 (s, 9H), 3.58–3.63
(m, 1H), 3.75–3.84 (m, 2H), 3.80 (s, 3H), 3.86–3.92 (m,
1H), 4.43–4.54 (m, 2H), 4.56–4.74 (ab, 2H, J=11.1), 6.86
(d, 2H, J=8.6), 7.2 (d, 2H, J=8.3), 7.44–7.49 (m, 2H),
7.57–7.62 (m, 1H), 8.02–8.04 (m, 2H); 13C NMR (100
MHz) l −5.56, −5.53, 18.1, 25.8, 55.2, 62.9, 63.7, 63.8,
72.7, 75.2, 113.8, 128.4, 129.6, 129.7, 129.8, 133.6, 159.4,
166.2; HRMS calcd for [C25H35O5Si+Na]+ 508.2244, obsd.
508.2258.
Characterization data for PMB ethers of 1, 4–11:
Compound 1: Rf=0.5 (ethyl acetate/hexane, 1/9); 1H
NMR, HRMS—Reported in J. Org. Chem. 1999, 64, 8943;
13C NMR: (100 MHz) l 15.7, 20.7, 22.0, 22.9, 25.1, 31.2,
34.2, 39.9, 47.9, 54.9, 69.7, 78.0, 113.3, 129.0, 130.9, 158.7.
Compound 4: Rf=0.4 (ethyl acetate/hexane, 15/85); 1H
NMR (300 MHz) l 2.16 (s, 3H), 2.69 (t, 2H, J=6.2 Hz),
3.70 (t, 2H, J=6.4), 3.0 (s, 3H), 4.43 (s, 2H), 6.87 (d, 2H,
J=8.5), 7.24 (d, 2H, J=8.6); 13C NMR (100 MHz) l 30.4,
43.8, 55.3, 64.9, 72.9, 113.8, 129.3, 130.1, 159.2; HRMS
calcd for [C12H16O3+Na]+ 231.0997, obsd. 231.1002.
Compound 5: Rf=0.5 (ethyl acetate/hexane, 1/9); 1H
NMR (300 MHz) l 1.35 (s, 6H), 2.19 (s, 3H), 2.66 (s, 2H),
3.79 (s, 3H), 4.39 (s, 2H), 6.86 (d, 2H, J=8.4), 7.24 (d, 2H,
Compound 11: Rf=0.5 (ethyl acetate/hexane, 15/85); 1H
NMR (300 MHz) l 3.21–3.25 (m, 1H), 3.60 (dd, 1H,
J=11.5, 5.2 Hz), 3.76–3.78 (m, 1H), 3.80 (s, 3H), 3.82 (dd,
1H, J=11.5, 3.1), 4.56 (d, 2H, J=2.6), 6.88 (d, 2H, J=8.6
Hz), 7.26–7.36 (m, 7H); 13C NMR (100 MHz) l 55.3, 55.9,
61.2, 69.6, 73.1, 113.8, 125.7, 128.1, 128.2, 129.4, 129.9,
136.9, 159.3; HRMS calcd for [C17H18O3+Na]+ 293.1154,
obsd. 293.1163.
9. Compound 10 was prepared from the corresponding azi-
dotriol via benzoylation of the dibutylstannylene ketal
followed by silylation. Full experimental details will be
published elsewhere.